Next Article in Journal
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
Next Article in Special Issue
Role of Dapagliflozin in Ischemic Preconditioning in Patients with Symptomatic Coronary Artery Disease—DAPA-IP Study Protocol
Previous Article in Journal
Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery
 
 
Systematic Review

Article Versions Notes

Pharmaceuticals 2024, 17(6), 708; https://doi.org/10.3390/ph17060708
Action Date Notes Link
article xml file uploaded 30 May 2024 09:58 CEST Original file -
article xml uploaded. 30 May 2024 09:58 CEST Update -
article pdf uploaded. 30 May 2024 09:58 CEST Version of Record https://www.mdpi.com/1424-8247/17/6/708/pdf-vor
article html file updated 30 May 2024 10:00 CEST Original file -
article xml file uploaded 31 May 2024 09:18 CEST Update -
article xml uploaded. 31 May 2024 09:18 CEST Update https://www.mdpi.com/1424-8247/17/6/708/xml
article pdf uploaded. 31 May 2024 09:18 CEST Updated version of record https://www.mdpi.com/1424-8247/17/6/708/pdf
article html file updated 31 May 2024 09:19 CEST Update https://www.mdpi.com/1424-8247/17/6/708/html
Back to TopTop